CORE
🇺🇦
make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
DUO: A phase 3 trial of the PL3K-delta,gamma inhibitor IPI-145 versusofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphorytic lymphoma.
Author
Baker Bartrum W.
Callgarls-Capplo Federico
+16 more
Cosolo Walter
Cymbalista Florence
Davids Matthew Steven
Delgado Julio
Easell James H.
Flinn Ian
Hallek Michael
Han Lixin
Harris Patricia
Hillman Peter
Jaeger Ulrich
Kelly Patrick Francis
Offner Fritz
Patterson Fiona
Stilgenbauer Stephan
Wright David Donald
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
01/01/2014
Field of study
Full text link
Kölner UniversitätsPublikationsServer
DUO: a phase 3 trial of the PL3K-delta,gamma inhibitor IPI-145 versus ofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphorytic lymphoma
Author
Baker Bartrum W
Callgarls-Capplo Federico
+16 more
Cosolo Walter
Cymbalista Florence
Davids Matthew Steven
Delgado Julio
Easell James H
Flinn Ian
Hallek Michael
Han Lixin
Harris Patricia
Hillman Peter
Jaeger Ulrich
Kelly Patrick Francis
Offner Fritz
Patterson Fiona
Stilgenbauer Stephan
Wright David Donald
Publication venue
Publication date
01/01/2014
Field of study
Full text link
Kölner UniversitätsPublikationsServer
Ghent University Academic Bibliography
Full text link
